REFOCUS-HTN US
Clinical Trial Grant
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
December 16, 2025
End Date
February 28, 2027
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
December 16, 2025
End Date
February 28, 2027